INTRODUCTION
Stem cells represent populations of cells that can give rise to all kinds of tissue types necessary to constitute an organ. Traditional understandings on stem cells were mainly derived from hematopoietic stem cells in the model where aplastic bone marrow cells damaged by destructive radiation was repopulated using bone marrow transplantation (1) . Over the last decades, studies on this cell population, namely hematopoietic stem cells have revealed much of unique properties not found in other cell types, such as self-renewal division, a mitotic division leading to a production of same stem cells, or asymmetric division, a unique division leading to un-equal production of daughter cells from same mother cells (2) . Although the regulatory mechanisms controlling the selfrenewing process or asymmetric division might have the key to more efficient use of stem cell in expansion culture or genetic modification, they still remain largely unknown awaiting further research. Another characteristic of stem cells inferred from hematopoietic stem cell is their extensive heterogeneity even after the highest purification process that currently available. The most important character of these stem cells, however, is their life-long reconstitutive activity as demonstrated by the long-term repopulating ability in animal transplantation model and specific cultures designed for in vitro assay (3) . While the regulatory mechanisms for hematopoietic stem cells have been under active investigation, unexpected breakthroughs were made in other aspects of stem cell biology. One is the finding that adult hematopoietic stem cells give rise to many other tissue type in addition to blood cells, such as neuronal or muscle cells. Similar surprising findings continue to unveil the previously hidden pluripotency of adult stem. A series of these new findings in stem cell differentiation initially provoked a big chaos in the classical concept of cell development and differentiation. New concepts of retro-differentiation, plasticity in differentiation, and existence of very primitive pluripotent stem cells are emerging. Furthermore, a novel issue on stem cell identity has been addressed as to whether stem cells exist as a distinct clone in each organ and maintained throughout the development (clonal nature) or they are rather product of organ function to maintain integrity of each organ (functional nature) (4) .
Another breakthrough in the stem cell area is the success in establishing human embryonic stem cells (5) , which has triggered a vigorous debate between ethics and scientific merit of their use. Human embryonic stem cells can give rise to a greater numbers of tissue type from single cell nature (6) (7) (8) (9) (10) (11) (12) and continue to self-renew to the extent that adult stem cells can never achieve. Despite these attractive features in embryonic stem cells, still many hurdles ahead before clinical use
Three-Dimensional Approach to Stem Cell Therapy
Recent progress in stem cell research is opening a new hope for cell therapy in regenerative medicine. Two breakthroughs were made in the stem cell era, one, new discoveries in multipotentiality of adult stem cells beyond the traditionally appreciated extent, and the other, establishment of pluripotent stem cell from human embryo. In addition to the newly identified multipotentiality of adult stem cells, their ability to be trans-differentiated toward other tissue types (stem cell plasticity) as well as to migrate toward the site of tissue damage make adult stem cells particularly attractive choice for stem cell based therapy. Stem cell therapy for organ regeneration, therefore, could be approached from three distinct dimensions: first, direct differentiation of multi-potent stem cells toward desired tissue types; secondly, regeneration of specific tissues through in vivo stem cell plasticity, and lastly, by tissue-specific stem cells from many types of organs. While each approach in stem cell therapy poses distinctive limitations for their successful clinical applications, understanding regulatory mechanisms of stem cell selfrenewal and their in vivo engraftment will mostly extend their medical efficacy of stem cell based therapy. Therefore, this review, focusing on stem cell-based cell therapy, will address discussions mostly to adult stem cells, rather than covering both types of stem cells, which should be beyond the current extent of scope.
MULTIPOTENTIALITY OF ADULT STEM CELLS
It has been a general concept that adult stem cells, in contrast to embryo-derived stem cells that have a totipotent differentiation potential, are limited in their cell types that can be derived from a given source of adult stem cells. In addition, it has been well accepted that this limitation is principally determined by their developmental origin, in such a way that the ectoderm-derived cells give rise to cells of ectodermal origin and those from the mesoderm give rise to cells of mesodermal origin. Furthermore, the developmental process has been thought to be irreversible process associated with lineage determination. However, series of new discoveries prompted the change of these classical concept awaiting emerge of new concept for cell development. In 1998, Geiger et al. (13) performed an experiment as to whether the adult cell would become like embryonic cells in a microenvironment that normal developmental process is occurring. They harvested bone marrow hematopoietic stem cells derived from transgenic mice for human beta globin gene and injected into blastocysts of developing mice. The resulting mice demonstrated a developmental chimerism, i.e., existence of donor-derived cells at various stages of development, including york sac, fetal liver, and adult bone marrow. The notion from this remarkable observation was that, given a certain microenvironment, the adult cells could also participate in the developmental process going backward in their developmental clock. Similarly, erythrocytes derived from adult donor did express the embryo-type hemoglobin ( -globin andglobin), suggesting that the gene expression program in adult genome could be reprogrammed in fetal microenvironment toward that in fetal genomic program. This intriguing observation of developmental plasticity of adult cells was rapidly extended to other models of developmental plasticity to investigate the extent of plasticity that adult stem cells can have. From early 2000, such trials brought up several remarkable observations that adult stem cells indeed have the differentiation potential beyond the developmental origin. The first evidence was obtained injecting neuronal precursor cells into blastocyst of developing mice (14) . In this experiment, adult transgenic mice expressing -galactosidase (lacZ) gene provided neural progenitor cells in the form of collection of immature cells, called neurosphere. After injection into blastocysts, the donor-derived neurosphere was tracked for their contribution to various types of cells. Surprisingly, the neurosphere, which was of ectodermal origin, was found to contribute to most of the tissues including intestine, heart, liver, mesonephron, as well as brain and notocord. This was the first demonstration that adult stem cells have a higher differentiation potential than previously thought beyond the developmental barrier, although, some criticisms were raised for possible contamination of other primitive stem cell population. However, on May 1991, Krause et al. (15) provided even stronger observations using single cell suspensions. In their experiment (schematically illustrated in Fig. 1 ), hematopoietic stem cells in bone marrow was purified using surface markers (CD34+ Sca-1+). The purified cells then were labeled with a lipid membrane-binding dye, PKH26, and transplanted into another mouse. Forty eight hours after transplantation, the bone marrow of primary transplanted mice were harvested and the labeled cells were isolated at a single-cell level under microscopic guidance. These single cells were inoculated into blastocysts for further development of the embryo, then tracked down for the distribution of the labeled cells muscular dystrophy (DMD), transplantation of hematopoietic stem cells as well as muscle stem cells (SP cells, see below for description) would reconstitute the dystrophin-positive muscle cells by 10-30% when examined 12 weeks after transplantation. This observation is particularly interesting in that stem cell transplantation could be potentially used for systemic delivery of therapeutic cells to broad areas of injury in the body.
Many similar observations were made for the plasticity of adult stem cells. In addition to the listed examples, many other tissues such as neuronal tissue (26, 27), renal tissue (28-30), cartilage and bone (31-33) have been shown to be derived from in vivo transplanted bone marrow cells.
Furthermore, in most of cases, the stem cell plasticity is bi-directional, i.e., bone marrow cells can differentiate into other tissues, and vice versa. For example, muscle stem cells, certain portion of hepatic tissues and neuronal tissues could differentiate into blood etc. (14, (19) (20) (21) 25 , 26, 28, 33-39) (summarized in Fig. 2 ).
TISSUE-SPECIFIC STEM CELLS
In addition to the multipotentiality of stem cells that can give rise to various tissue types and their plasticity that can lead to different tissue types, adult stem cells provide additional potential way of tissue regeneration, i.e., through tissuespecific stem cells. It has been shown that many of adult organs have their own stem cells that retain some multipotentiality, albeit to a variable extent depending on the organ type. These cells include those from the pancreas, neuron, bone and cartilage, liver, skin, and even adipose tissues (summarized in Fig. 3) .
It is, however, important to note that the limited ranges of differentiation potential does not necessarily mean their limitation for used in cell therapy. Rather, it could be a better source for stem cell therapy if it is more committed to a specific lineage of tissue when purity of cell type are to be taken.
Pancreatic stem cell
It has been known from traditional observation that the pancreatic ductal epithelium is the source of various islet-associated endocrine cell populations including alpha, beta, and delta cells in the islets of Langhans. Therefore, the pancreatic ductal epithelium has been believed to contain stem cells responsible for pancreatic endocrine cells but to easily differentiate upon in vitro culture, thereby losing the insulin-secreting ability (40, 41). In 2000, Ramiya et al. and Bonner-Weir et al. simultaneously developed series of culture method by which pancreatic ductal stem cells can proliferate maintaining their ability to differentiate into islet-progenitor cells (IPC) and accordingly ability to differentiate into insulinsecreting beta cells (42, 43). In these reports, the islet-producing cells were developed from crude ductal pancreatic epithelium and thus obtained IPCs were maintained in up to 150 serial passages (42) retaining their ability to secrete insulin and glucagons upon terminal differentiation in vitro. Subsequent injection of these islet cells into the renal capsule demonstrated that thus prepared islet cells led to neovascularization in the local environment, and secrete insulin in vivo. According to the report, the blood glucose levels of diabetic mice (non-obese diabetic: NOD) were maintained up to 5 ( 1 99 9) J a n k s o n e t a l. (1 9 9 9 ) G u s s o n i e t a l. (1 9 9 9 ) F e rr a ri e t a l. (1 9 9 8 (58) . In contrast, CD34+ CD38+ cells are more enriched with progenitor cells restricted in their potential spectrum of lineages and in their selfrenewing potential, which are often read out either by CFU-S12, CFU-14, or colony-forming assay in semi-solid medium (59) . However, recent evidence revealed that additional populations that had been previously neglected (i.e., primitive CD34-cell populations) could be engrafted in NOD/ SCID mice with low clonogenicity in long-term culture, suggesting that this population could be an even more primitive cell population (60) .
In addition to purification of HSCs by cell surface markers, functional characteristics of HSCs using their intrinsic dyeefflux effect were also described (61) . These dye-effluxing cell population, called side population (SP) cell, are characterized by dim Hoechst 33342 staining when activated by UV light due to verapamil-sensitive dye efflux function (Fig. 5) . The SP cells were weak in CD34 expression, and lacked most of lineage-specific markers. Interestingly, like HSCs, multipotent stem cells from other tissues such as muscle and liver shares common phenotype, suggesting that the SP cell phenotype might be a universal stem cell marker (62) .
ONTOLOGICAL DIFFERENCE IN HSCS
HSCs have been found to exist in different forms of hematopoietic organs throughout the ontological difference, i.e., adult bone marrow, neonatal cord blood, and fetal liver. Each stage of HSCs is characterized by differential functional characteristics in terms of in vivo self-renewal capacity, in vitro proliferation potential, and optimal growth factor requirement (63) (64) (65) . For example, fetal liver HSCs were characterized by the highest in vitro proliferation potential and in vivo self-renewing capacity, while adult bone marrow cells have the lowest position in both terms, and umbilical cord blood is in the intermediate position (66) . The basis for these functional differences among ontologically different populations remains unknown. Previously we have performed a series of gene expression studies to investigate the distinct gene expression patterns among different stages of ontology (67) . We found that series of gene expression pattern is conserved during in vivo differentiation from CD34+CD38-cells to CD34+ CD38+ cells and during in vitro differentiation mediated by growth factor stimulation. Interestingly, similar difference was also conserved during ontology-related differences in gene expression in such a way that the gene expression pattern in ontologically earlier stage HSC is more close to the patterns in growth factor-stimulated cells. These findings led us to speculate that there is a certain stage of HSC activation common to in vitro stimulation and in vivo activation called "priming"and according to this hypothesis, fetal liver and umbilical cord blood HSC mimic the state already growth factor-stimulated and primed in the activation process, when compared to adult bone marrow stem cells (schematically illustrated in Fig. 6 ).
the stem cell plasticity, which can regenerate many tissues using different types of stem cells. The problem of this approach is that we can not answer such questions as 'what is the controlling mechanisms?' or 'how does this process occur?'To be useful for cell therapy, these phenomenological descriptions of plasticity should be further dissected into the regulatory mechanisms so that the efficiency of organ regeneration by the process could reach a therapeutic level. The third dimension of stem cell therapy would be through tissue-specific stem cells, such as pancreatic stem cells, hematopoietic stem cells for lympho-myeloid reconstitution, or liver stem cells. The advantage of the tissue-specific stem cells is that it can produce a highly homogenous population of the differentiated cells unlike pluripotent embryonic stem cells, where the possibility of improper or inappropriate differentiation remains to be cleared. Again, however, the major obstacle of this approach is that the cell number is limited for a medically effective cell therapeutic dose.
Therefore, molecular mechanisms for the expansion of adult stem cells and differentiation of pluripotent stem cells should be elucidated before major benefit from stem cell therapy is envisioned.
